Clinical Trial Update: Brachial Artery t-PA Release in Heart Transplant Recipients [NA]

View source ↗

Summary

A clinical trial evaluating brachial artery tissue plasminogen activator release in heart transplant recipients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation

Drugs mentioned

• tissue plasminogen activator (t-PA) (tissue plasminogen activator)

Snippet

Sponsor: Vanderbilt University | Conditions: Heart Transplantation | NA | Status: WITHDRAWN